2014 SABCS Public Friday
Read More
`San Antonio, TX - SABCS 2014 San Antonio Breast Cancer Symposium - Robertson JFR discusses "S6-04. Fulvestrant 500 mg versus anastrozole as first-line treatment for advanced breast cancer: Overall survival from the Phase II 'FIRST' study" during General Session 6 here today, Friday December 12, 2014. during the San Antonio Breast Cancer Symposium being held at the Henry B. Gonzalez Convention Center in San Antonio, TX. Over 7,500 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Photo by © MedMeetingImages/Todd Buchanan 2014 Technical Questions: todd@medmeetingimages.com
